Clinical Study

Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Participants With Early Stage Relapsing Remitting Multiple Sclerosis (Rrms)

Posted Date: May 15, 2019

  • Investigator: Aram Zabeti
  • Specialties:
  • Type of Study: Drug

Consonance MN39159

Criteria:

-Have A Definite Diagnosis Of Rrms, As Per The Revised Mcdonald 2010 Criteria -Have A Length Of Dis

Keywords:

Ocrelizumab , Relapsing Remitting

For More Information:

Molly Winters
513-558-0269
molly.winters@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.